Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Furuse

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)]M Fukuoka, S Negoro, S Kudo, et al.
British Journal of Cancer|January 26, 2000
Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapyT Kawaguchi, S Yamamoto, N Naka, et al.
British Journal of Cancer|January 1, 1997
A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasisK Furuse, T Kamimori, M Kawahara, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study GroupK Furuse, K Kubota, M Kawahara, et al.
Japanese Journal of Clinical Oncology|October 1, 1994
Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology GroupY Ariyoshi, M Fukuoka, K Furuse, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients]M Yamamoto, Y Ariyoshi, K Hasegawa, et al.
The American Journal of Surgical Pathology|August 1, 1979
Small cell carcinoma of the lung and its histological origin. Report of a caseT Hashimoto, M Fukuoka, S Nagasawa, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II studyY Nakai, K Furuse, M Ohta, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 1999
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998B R Leigh, D R Gandara, J J Crowley, et al.
Journal of Surgical Oncology|November 23, 2000
Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patientsM M Song, Y Nio, M Dong, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)]M Fukuoka, S Negoro, S Kudo, et al.
British Journal of Cancer|January 26, 2000
Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapyT Kawaguchi, S Yamamoto, N Naka, et al.
British Journal of Cancer|January 1, 1997
A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasisK Furuse, T Kamimori, M Kawahara, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study GroupK Furuse, K Kubota, M Kawahara, et al.
Japanese Journal of Clinical Oncology|October 1, 1994
Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology GroupY Ariyoshi, M Fukuoka, K Furuse, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients]M Yamamoto, Y Ariyoshi, K Hasegawa, et al.
The American Journal of Surgical Pathology|August 1, 1979
Small cell carcinoma of the lung and its histological origin. Report of a caseT Hashimoto, M Fukuoka, S Nagasawa, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II studyY Nakai, K Furuse, M Ohta, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 1999
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998B R Leigh, D R Gandara, J J Crowley, et al.
Journal of Surgical Oncology|November 23, 2000
Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patientsM M Song, Y Nio, M Dong, et al.
Pageof 21